Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis

BACKGROUND: Escitalopram is selective serotonin reuptake inhibitors (SSRIs) and one of the most commonly prescribed newer antidepressants (ADs) worldwide. We aimed to explore the efficacy, acceptability and tolerability of escitalopram in comparison with other ADs in the acute-phase treatment of maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Juntao, Song, Xiaoyong, Wang, Chaoyang, Lin, Xuhong, Miao, Mingsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675869/
https://www.ncbi.nlm.nih.gov/pubmed/38001423
http://dx.doi.org/10.1186/s12888-023-05382-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675869/
https://www.ncbi.nlm.nih.gov/pubmed/38001423
http://dx.doi.org/10.1186/s12888-023-05382-8

Ejemplares similares